Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Patent
1994-06-03
1998-05-12
Lukton, David
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
514 18, 514 19, A61K 3806
Patent
active
057506485
ABSTRACT:
The present invention is directed to the preparation and use of retroviral protease inhibitors and combinations of retroviral protease inhibitors which are effective in preventing the replication of mammalian retroviruses, such as human immunodeficiency virus (HIV).
REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4857507 (1989-08-01), Rosenberg et al.
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
Roberts et al, Science, 248, 358-361, (1990).
Erickson et al, Science, 249, (1990).
S.J. Fittkau, J. Prakt. Chem., 315, 1037 (1973).
Parikh et al, J. Am. Chem., 89, 5505 (1967).
Reetz et al, Angew. Chem. Int. Ed. Eng., 26:11 1141-1143 (1987).
Miller et al, Science, 246, 1149 (1989).
J.A. Martin, Drugs of the Future, 16(3), 210-212 (1991).
Kagayama et al, Antimicrobial Agents and Chemotheraphy 37, 810-817 (1993).
Lam et al, "De Novo Design and Discovery of Potent, Nonpeptidal HIV-1 Protease Inhibitors", paper 96 at the 205th American Chemical Society National Meeting, Medicinal Chemistry Division, Denver, CO, Mar. 28-Apr. 2, 1993.
Dorsey et al, "L-735,524: The Rational Design of a Potent and Orally Bioavailable HIV Protease Inhibitor", paper 6 at the 206th American Chemical Society National Meeting, Medicinal Chemistry Division, Chicago, IL, Aug. 22-27, 1993.
Wei et al, J. Med. Chem., 36, 249-255 (1993).
Hoffman et al, J. Med. Chem., 35, 3784-3791 (1992).
Saari et al, J. Med. Chem. 35, 3792-3802 (1992).
Romero et al, J. Med. Chem., 36, 1505-1508 (1993).
Hargrave, J. Med. Chem., 34, 2231-2241 (1991).
Merluzzi, Science, 250, 1411-1413 (1990).
Williams et al, J. Med. Chem., 36, 1291-1294 (1993).
Hsu et al, Proc. Natl. Acad. Sci. USA. 909, 6395-6399 (1993).
Tam et al, "Tat Inhibitors: A New Class of Anti-HIV Agents" paper 372, at the 204th American Chemical Society National Meeting. Organic Chemistry Division, Washington, DC, Aug. 23-28 (1992).
Meek et al, Nature, 343, (1990).
T.J. McQuade et al, Science, 247, 454-456 (1989).
Rich et al, Peptide Inhibitors of Proteases, 511-520.
Rosenberg et al, J.Med.Chem., 30, 1224-1228, (1987).
Pearl et al, Nature, 328, 482 (1987).
Chang Min S.
DeCrescenzo Gary A.
Getman Daniel P.
Mueller Richard A.
Ottinger James C.
G.D. Searle & Co.
Lukton David
LandOfFree
Retroviral protease inhibitors and combinations thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibitors and combinations thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors and combinations thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-980018